Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 1
2004 1
2005 1
2006 1
2007 1
2015 3
2016 1
2017 2
2018 2
2020 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Transplant-Related Carcinoma"
Page 1
Effects of transplantation-related immunosuppression on co-existent neuroendocrine tumours.
Shah HA, Faulkes R, Coldham C, Shetty S, Shah T. Shah HA, et al. QJM. 2022 Oct 25;115(10):661-664. doi: 10.1093/qjmed/hcac036. QJM. 2022. PMID: 35143660 Free PMC article.
AIM: We aimed to quantify the behaviour of NENs under solid-organ transplant-related immunosuppression. DESIGN: This was an observational, retrospective case series. ...CONCLUSIONS: NENs demonstrate indolent behaviour in the presence of transplant-r …
AIM: We aimed to quantify the behaviour of NENs under solid-organ transplant-related immunosuppression. DESIGN: This was an …
Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma.
Ioannou GN. Ioannou GN. Liver Transpl. 2017 May;23(5):652-662. doi: 10.1002/lt.24690. Liver Transpl. 2017. PMID: 28006870 Review.
Transplant-related survival benefit is calculated as the difference between life expectancy with transplantation and life expectancy without transplantation. ...The most promising application of survival benefit-based prioritization would be to replace the current s …
Transplant-related survival benefit is calculated as the difference between life expectancy with transplantation and life expe …
De Novo Skin Neoplasms in Liver-Transplanted Patients: Single-Center Prospective Evaluation of 105 Cases.
Paganelli A, Magistri P, Kaleci S, Chester J, Pezzini C, Catellani B, Ciardo S, Casari A, Giusti F, Bassoli S, Di Sandro S, Pellacani G, Farnetani F, Di Benedetto F. Paganelli A, et al. Medicina (Kaunas). 2022 Oct 13;58(10):1444. doi: 10.3390/medicina58101444. Medicina (Kaunas). 2022. PMID: 36295604 Free PMC article.
However, most of the existing literature is focused on kidney transplant-related non-melanoma skin cancers (NMSCs). Conflicting data have been published so far on NMSC incidence among liver transplant recipients (LTRs), and whether LTRs really should be considered a …
However, most of the existing literature is focused on kidney transplant-related non-melanoma skin cancers (NMSCs). Conflictin …
Pro (With Caution): Extended oncologic indications in liver transplantation.
Mazzaferro V, Battiston C, Sposito C. Mazzaferro V, et al. Liver Transpl. 2018 Jan;24(1):98-103. doi: 10.1002/lt.24963. Epub 2017 Dec 8. Liver Transpl. 2018. PMID: 29077253
The success of liver transplantation (LT) in curing cancer (particularly hepatocellular carcinoma and hepatic metastases from neuroendocrine tumors) is based on the augmented oncologic potentials of the total hepatectomy and on restrictive criteria applied to patient selec …
The success of liver transplantation (LT) in curing cancer (particularly hepatocellular carcinoma and hepatic metastases from neuroen …
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
Todisco E, Gigli F, Ronchini C, Amato V, Sammassimo S, Pastano R, Parma G, Lapresa MT, Bertolini F, Corsini C, Gregato G, Poletti C, Pelicci PG, Alcalay M, Colombo N, Tarella C. Todisco E, et al. Int J Cancer. 2022 Nov 15;151(10):1791-1803. doi: 10.1002/ijc.34162. Epub 2022 Jul 2. Int J Cancer. 2022. PMID: 35695283 Free PMC article.
Three of these 11 patients experienced refractory disease, and 8 had complete remission. During a 6.8 months (range 2.3-49) median observation time, 3 out of 16 patients were alive, with one surviving patient free of both solid and hematological tumors. Ten patients died b …
Three of these 11 patients experienced refractory disease, and 8 had complete remission. During a 6.8 months (range 2.3-49) median observ …
Allogeneic stem cell transplantation for the treatment of advanced solid tumors.
Bregni M, Bernardi M, Ciceri F, Peccatori J. Bregni M, et al. Springer Semin Immunopathol. 2004 Nov;26(1-2):95-108. doi: 10.1007/s00281-004-0164-4. Epub 2004 Sep 11. Springer Semin Immunopathol. 2004. PMID: 15378271 Review.
The use of non-myeloablative, immunosuppressive conditioning regimens offers the opportunity to achieve a full-donor engraftment with reduced transplant-related complications and mortality, enabling also patients of advanced age and with co-morbidities to receive an …
The use of non-myeloablative, immunosuppressive conditioning regimens offers the opportunity to achieve a full-donor engraftment with reduce …
Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Su F, et al. Gastroenterology. 2016 Feb;150(2):441-53.e6; quiz e16. doi: 10.1053/j.gastro.2015.10.043. Epub 2015 Oct 30. Gastroenterology. 2016. PMID: 26522262
Among transplant recipients, increasing age was associated with increasing post-transplantation mortality. There was little difference in 5-year transplant-related survival benefit between different age groups who had the same Model for End-Stage Liver Disease sc …
Among transplant recipients, increasing age was associated with increasing post-transplantation mortality. There was little difference in 5- …
Nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Baron F, Beguin Y. Baron F, et al. J Hematother Stem Cell Res. 2002 Apr;11(2):243-63. doi: 10.1089/152581602753658448. J Hematother Stem Cell Res. 2002. PMID: 11983097 Free article. Review.
Preliminary results showed that NMSCT were feasible with a relatively low transplant-related mortality (TRM), even in patients older than 65 years. In addition, strong antitumor responses were observed in several hematological malignancies as well as in some …
Preliminary results showed that NMSCT were feasible with a relatively low transplant-related mortality (TRM), even in patients …
Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
Salim TI, Nestlerode LC, Lucatorto EL, Wasserman TL, Din HA, Landsittel DP, Tevar AD, Johnson JT, Duarte-Rojo A, Dunn MA. Salim TI, et al. Am J Gastroenterol. 2020 Jun;115(6):859-866. doi: 10.14309/ajg.0000000000000609. Am J Gastroenterol. 2020. PMID: 32235146
We hypothesized that frailty or sarcopenia could identify the risk for common serious transplant-related adverse respiratory events. METHODS: For 107 patients (74 men, 33 women) transplanted over 1 year, we measured frailty with gait speed, chair stands, and Karnofs …
We hypothesized that frailty or sarcopenia could identify the risk for common serious transplant-related adverse respiratory e …
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.
Cortesi PA, Belli LS, Facchetti R, Mazzarelli C, Perricone G, De Nicola S, Cesana G, Duvoux C, Mantovani LG, Strazzabosco M; European Liver and Intestine Transplant Association (ELITA). Cortesi PA, et al. J Viral Hepat. 2018 Jul;25(7):791-801. doi: 10.1111/jvh.12877. Epub 2018 Mar 8. J Viral Hepat. 2018. PMID: 29406608
The population was substratified according to HCC presence and, in those without HCC, according to the MELD score at listing. Data on DAAs effectiveness were estimated using a cohort of patients still followed by 11 transplant centres of the European Liver and Intestine Tr …
The population was substratified according to HCC presence and, in those without HCC, according to the MELD score at listing. Data on …
19 results